Section I--Etiology -- 1. The Genetics of Narcolepsy -- 2. Orexin (Hypocretin) and Narcolepsy -- 3. Precipitants of Narcolepsy: Vaccines and Infections -- Section II--Clinical Considerations -- 4. Epidemiology of Narcolepsy -- 5. Diagnostic Criteria and Delay in Diagnosis of Narcolepsy -- 6. Narcolepsy in Childhood -- 7. Narcolepsy in the Older Adult -- 8. Hypnagogic Hallucinations and Sleep Paralysis -- 9. Symptomatic Narcolepsy or Hypersomnia, with and without Hypocretin (Orexin) Deficiency -- 10. Hypersomnias Other than Narcolepsy: Differential Diagnosis -- 11. Narcolepsy and Other Comorbid Medical Illnesses -- 12. Sleep Disorders Comorbidities in Narcolepsy and their Management -- 13. Neuroimaging of Narcolepsy -- Section III--Psychosocial Considerations -- 14. Quality of Life and Psychosocial Issues in Narcolepsy: Implications for Management -- 15. Narcolepsy, Intimacy and Sexuality -- 16. Memory and Cognition in Narcolepsy -- 17. Psychoanalysis and Narcolepsy -- 18. Dreaming in Narcolepsy -- 19. Narcolepsy and Mental Illness -- 20. Narcolepsy, Driving and Traffic Safety -- Section IV--Management -- 21. Overview of Management of Narcolepsy -- 22. Modes of Action of Drugs Related to Narcolepsy: Pharmacology of Wake-Promoting Compounds and Anticataplectics -- 23. Modafinil/Armodafinil in the Treatment of Narcolepsy -- 24. Sodium Oxybate in the Treatment of Narcolepsy -- 25. Pregnancy and Anaesthesia in Narcolepsy -- 26. Emerging Treatments for Narcolepsy -- 27. Behavioral and Non-Pharmacological Management of Narcolepsy -- Section V--Health Care Delivery and Medico-Legal Considerations -- 28. Narcolepsy and Developmental Disability -- 29. Succeeding in School and in the Workplace with Narcolepsy -- 30. Medico-Legal Aspects of Disability in Narcolepsy -- 31. The Affordable Care Act and the Future of Sleep Medicine.